Actively Recruiting
Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
Led by Inna Chen, MD · Updated on 2024-10-02
274
Participants Needed
1
Research Sites
293 weeks
Total Duration
On this page
Sponsors
I
Inna Chen, MD
Lead Sponsor
R
Roche Pharma AG
Collaborating Sponsor
AI-Summary
What this Trial Is About
Pancreatic and biliary tract cancer are ones of the leading causes of cancer-related deaths. During the course of illness, these patients often experience marked physical suffering, psychological distress and frequent unplanned resource-demanding hospitalized care. Patients with pancreatic and lung cancer have highest rates of unplanned hospitalizations. Investigator initiated prospective "Study of Supportive Application with Integrated Patient-Reported Outcomes in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)" is to be initiated based on the great need for optimizing treatment care, reducing hospitalizations and improving outcomes.
CONDITIONS
Official Title
Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 and over
- Confirmed advanced lung (NSCLC) or pancreatic cancer by cytology or histology
- Provided written informed consent before any study procedures
- Planning to receive first-line systemic anticancer therapy within 2 weeks
- Performance status: ECOG 0-2
- Have access to the internet
- Able to read and respond to questions or complete them with minimal assistance from an interpreter or family member
You will not qualify if you...
- No mobile device available
- Showing signs of overt psychopathology or cognitive dysfunction
- Any medical condition considered by the investigator as significant enough to compromise patient safety or affect study assessments
- Currently participating in another interventional study that might interfere with this study (participation in treatment-only protocols allowed)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Herlev & Gentofte University Hospital, Denmark
Herlev, Denmark, 2730
Actively Recruiting
Research Team
I
Inna M Chen, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here